PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 219 results · Off-label Promotion  · Clear
🔒 Subscribers only
AUTH/3257/10/19
Off-label Promotion Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK
GlaxoSmithKline (GSK) voluntarily admitted that a sponsored promotional email for Trelegy Ellipta (ref PM-GB-FVU-EML-190028) sent on 16 September 2019 contained prescribing information dated Novemb…
Clauses: 4.1,4.3
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3275/10/19
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Britannia v Ever Pharma
Complainant: Britannia Pharmaceuticals complained about Ever Pharma’s promotion of Dacepton (apomorphine) for Parkinson’s disease motor fluctuations. Materials at issue: An email from an…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3175/3/19
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK misleadingly implied NICE endorsement for Anoro Ellipta and blurred licensed indication context
An anonymous health professional complained about a two-page Anoro Ellipta advertisement (ref UK/UCV/0028/18) in the February 2019 edition of Guidelines in Practice.Each page featured a prominent b…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3149/1/19
Off-label Promotion Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Endo Ventures breached ABPI Code over
An anonymous complainant (a concerned UK health professional) challenged a fluoxetine advertisement (ref FLUO 0010/2018) placed in Pulse by Endo Ventures Ltd.The ad included the claim “for treatm…
Clauses: 4.1,4.2
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3258/10/19
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached ABPI Code over Ozempic formulary guide omitting retinopathy risk (AUTH/3258/10
A contactable complainant (later joined by an ex-employee) complained about the promotion of Ozempic (semaglutide) by Novo Nordisk.Allegations included: company staff helping to write local formula…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3278/11/19
Off-label Promotion Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Strides Pharma UK Ltd breached ABPI Code over ‘The Licensed Vitamin D3 of Choice’ claim for Strivit-
An anonymous, non-contactable complainant challenged a journal advertisement for Strivit-D3 (colecalciferol) placed by Strides Pharma UK Ltd in the print edition of MIMS (September 2019).The headli…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3289/12/19
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bristol Myers Squibb and Pfizer
A UK health professional complained about prescribing information (PI) attached to a promotional email for Eliquis (apixaban) received in December 2019.The PI was last revised in July 2019, while t…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3169/3/19
Off-label Promotion Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Otsuka Europe
Otsuka Pharmaceuticals Europe Ltd made a voluntary admission that it might have breached the Code regarding updates to the Jinarc (tolvaptan) SPC.There were two parallel SPC revisions processed sep…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3058/8/18
Off-label Promotion Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Proveca letter on unlicensed/off-label
Two prescribing team pharmacists from a CCG (AUTH/3058/8/18) and a community pharmacist (AUTH/3060/8/18) complained about a Proveca letter (ref Sia/Legal/01) sent in August 2018 about supply/dispen…
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3140/12/18
Off-label Promotion Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Amgen
A health professional complained that Disclosure UK incorrectly showed they had received financial support (transfers of value) from Amgen.The complainant said they had never received support or ha…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3039/5/18
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Dr Falk
Tillotts complained about a Dr Falk Pharma UK Ltd advertisement for Budenofalk (budesonide) (ref DrF17/159).Budenofalk existed as multiple products sharing the root name: 3mg gastro-resistant capsu…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3036/4/18
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Concordia
An anonymous contactable UK health professional complained about a journal advertisement for Morphgesic SR 10mg modified release morphine sulphate (ref Con/MOR/PM/0021) published in Pulse, April 20…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3035/4/18
Off-label Promotion Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer breached ABPI Code over ambiguous Xarelto renal impairment claim implying use “with confidence
An anonymous UK health professional complained about a Bayer Xarelto (rivaroxaban) advertisement (ref UKXAR01180037d) placed in Pulse, April 2018.Headline claim: “Xarelto Protects Your High-Risk …
Clauses: 4.1,9.1
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3057/8/18
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
The head of prescribing and medicines management at a CCG complained about promotion of Victoza (liraglutide) by a named Novo Nordisk representative.Allegation: on 8 August 2018 the representative …
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3062/8/18
Off-label Promotion Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi Toujeo leavepiece
A consultant physician complained about a six-page A5 gate-folded promotional leavepiece for Toujeo (insulin glargine 300 units/mL) (SAGB.TJO.18.06.0924(1)).The leavepiece discussed the BRIGHT head…
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3118/11/18
Off-label Promotion Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Tesaro
The PMCPA Director opened a complaint (Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) ranked sponsors’ compliance with posting trial results to the EU Clinical Trials Register (E…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3123/11/18
Off-label Promotion Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Otsuka Europe voluntary admission
An Otsuka employee alleged Otsuka Europe was not transparent in its June 2018 response to the PMCPA in relation to earlier concerns about implementing SPC/prescribing information updates for Jinarc…
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3041/6/18
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Employee complaint
An Otsuka employee complained that processes for updating SPCs and prescribing information were inadequate, leading to delayed communication/implementation and potential patient safety risk. Produc…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/2945/3/17
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous community pharmacist complained about an NPA booklet, Managing COPD in the community, Resources for pharmacists (Ref UK/RET/0007/16), which carried both NPA and GlaxoSmithKline (GSK) l…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2973/8/17
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
An anonymous, non-contactable complainant alleged a named Bayer representative failed to declare a conflict of interest because her husband was a doctor at a named NHS trust and “gave her access�…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2943/3/17
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
An ex-employee of a service provider complained about a named Bayer employee’s conduct during an initial 2017 training course for contract sales representatives on Xarelto.The complaint alleged t…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2957/5/17
Off-label Promotion Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Astellas UK
Astellas UK voluntarily admitted that promotional materials referring to both Betmiga (mirabegron) and solifenacin (Vesicare) included prescribing information (PI) for Betmiga only.It also admitted…
Clauses: 4.3,4.4
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2971/8/17
Off-label Promotion Upheld 🏥 Other ▶ Video 🎙 Podcast
CCG v Thame Laboratories
Two CCG staff complained about a letter Thame Laboratories sent to a clinician about prescribing Sodibic Oral Solution (sodium bicarbonate) as a food supplement instead of Thamicarb Oral Solution (…
Clauses: 2,3.2,4.2
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2967/8/17
Off-label Promotion Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Consultant v Shire
A consultant complained about Shire.The complaint alleged omission of prescribing information and other obligatory information.Case reference: AUTH/2967/8/17.Complaint received: 08 August 2017.Appl…
Clauses: NONE
2017 🔒 Subscribe
← Prev 1 2 3 4 5 6 Next → Page 3 of 10 — 219 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews